155 related articles for article (PubMed ID: 38204216)
1. Long-term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction.
Kuchynka P; Podzimkova J; Marek J; Danek BA; Vitkova I; Kreidlova M; Roblova L; Kovarnik T; Simek S; Horak J; Habasko J; Linhart A; Palecek T
ESC Heart Fail; 2024 Apr; 11(2):859-870. PubMed ID: 38204216
[TBL] [Abstract][Full Text] [Related]
2. Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy.
Díez-López C; Salazar-Mendiguchía J; García-Romero E; Fuentes L; Lupón J; Bayés-Genis A; Manito N; de Antonio M; Moliner P; Zamora E; Catalá-Ruiz P; Caínzos-Achirica M; Comín-Colet J; González-Costello J
J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050230
[TBL] [Abstract][Full Text] [Related]
3. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
[TBL] [Abstract][Full Text] [Related]
4. High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction.
Cescau A; Van Aelst LNL; Baudet M; Cohen Solal A; Logeart D
ESC Heart Fail; 2017 Nov; 4(4):686-689. PubMed ID: 28752617
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry.
Adamo M; Godino C; Giannini C; Scotti A; Liga R; Curello S; Fiorina C; Chiari E; Chizzola G; Abbenante A; Visco E; Branca L; Fiorelli F; Agricola E; Stella S; Lombardi C; Colombo A; Petronio AS; Metra M; Ettori F
Eur J Heart Fail; 2019 Feb; 21(2):196-204. PubMed ID: 30549159
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of left ventricular reverse remodeling after catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction.
Okada M; Tanaka N; Oka T; Tanaka K; Ninomiya Y; Hirao Y; Yoshimoto I; Inoue H; Kitagaki R; Onishi T; Koyama Y; Okamura A; Iwakura K; Sakata Y; Fujii K; Inoue K
J Cardiol; 2021 May; 77(5):500-508. PubMed ID: 33272779
[TBL] [Abstract][Full Text] [Related]
8. A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.
Kimura Y; Okumura T; Morimoto R; Kazama S; Shibata N; Oishi H; Araki T; Mizutani T; Kuwayama T; Hiraiwa H; Kondo T; Murohara T
ESC Heart Fail; 2021 Apr; 8(2):1359-1368. PubMed ID: 33471966
[TBL] [Abstract][Full Text] [Related]
9. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy.
Matsumura Y; Hoshikawa-Nagai E; Kubo T; Yamasaki N; Furuno T; Kitaoka H; Takata J; Sugiura T; Doi Y
Am J Cardiol; 2013 Jan; 111(1):106-10. PubMed ID: 23040590
[TBL] [Abstract][Full Text] [Related]
11. The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.
Kan A; Fang Q; Li S; Liu W; Tao X; Huang K; Hu M; Feng Z; Gong L
ESC Heart Fail; 2023 Dec; 10(6):3340-3351. PubMed ID: 37697922
[TBL] [Abstract][Full Text] [Related]
12. Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry.
Mandoli GE; Pastore MC; Giannoni A; Benfari G; Dini FL; Rosa G; Pugliese NR; Taddei C; Correale M; Brunetti ND; Mazzeo P; Carluccio E; Mengoni A; Guaricci AI; Piscitelli L; Citro R; Ciccarelli M; Novo G; Corrado E; Pasquini A; Loria V; De Carli G; Degiovanni A; Patti G; Santoro C; Moderato L; Cicoira M; Canepa M; Malagoli A; Emdin M; Cameli M
ESC Heart Fail; 2023 Apr; 10(2):846-857. PubMed ID: 36448244
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence and predictors of left ventricular reverse remodeling in patients with recent onset dilated cardiomyopathy on tailored medical therapy].
Zhang J; Zou CH; Huang Y; Zhou Q; Zhang YH; Lyu R
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):315-20. PubMed ID: 27112609
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Reverse Remodeling in Recent Onset Idiopathic Dilated Cardiomyopathy Using Contemporary Echo Techniques.
Goland S; Fugenfirov I; Volodarsky I; Aronson H; Zilberman L; Shimoni S; George J
Isr Med Assoc J; 2018 Dec; 20(12):749-753. PubMed ID: 30550004
[TBL] [Abstract][Full Text] [Related]
15. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction.
Adachi Y; Kiyosue A; Ando J; Kawahara T; Kodera S; Minatsuki S; Kikuchi H; Inaba T; Kiriyama H; Hirose K; Shinohara H; Saito A; Fujiwara T; Hara H; Ueda K; Sakakura K; Hatano M; Harada M; Takimoto E; Akazawa H; Morita H; Momomura SI; Fujita H; Komuro I
Sci Rep; 2021 Jan; 11(1):239. PubMed ID: 33420237
[TBL] [Abstract][Full Text] [Related]
17. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
[TBL] [Abstract][Full Text] [Related]
18. Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling.
Cannata A; Manca P; Nuzzi V; Gregorio C; Artico J; Gentile P; Pio Loco C; Ramani F; Barbati G; Merlo M; Sinagra G
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751220
[TBL] [Abstract][Full Text] [Related]
19. Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.
Xu Y; Li W; Wan K; Liang Y; Jiang X; Wang J; Mui D; Li Y; Tang S; Guo J; Guo X; Liu X; Sun J; Zhang Q; Han Y; Chen Y
Circ Heart Fail; 2021 Jan; 14(1):e007944. PubMed ID: 33185117
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular reverse remodelling and its predictors in non-ischaemic cardiomyopathy.
Hnat T; Veselka J; Honek J
ESC Heart Fail; 2022 Aug; 9(4):2070-2083. PubMed ID: 35437948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
